More
Category: Levaquin
Minor changes to warning labels are not uncommon when dealing with prescriptions. In fact, they are to be expected. Despite rigorous clinical trials, there will always be a few rare, but unserious side effects, that are not noted during the initial FDA approval process. But these side effects should be
This week the U.S. Food and Drug Administration updated its previous warnings on a group of strong antibiotics known as fluoroquinolones. The FDA will now require additional information be printed on the boxes, labels and patient medication guides to include warnings of potentially serious side effects on muscles, joints and
